BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11292882)

  • 1. Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.
    Daum RS; Seal JB
    Crit Care Med; 2001 Apr; 29(4 Suppl):N92-6. PubMed ID: 11292882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.
    File TM
    Cleve Clin J Med; 2007 Aug; 74 Suppl 4():S6-11. PubMed ID: 17847173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents.
    Durmaz B; Durmaz R; Sahin K
    J Hosp Infect; 1997 Dec; 37(4):325-9. PubMed ID: 9457610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRSA--the tip of the iceberg.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008.
    Simor AE; Louie L; Watt C; Gravel D; Mulvey MR; Campbell J; McGeer A; Bryce E; Loeb M; Matlow A;
    Antimicrob Agents Chemother; 2010 May; 54(5):2265-8. PubMed ID: 20231402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV; Hawkey PM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of healthcare-associated methicillin-resistant Staphylococcus aureus.
    Hsu LY; Wijaya L; Tan BH
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):893-905. PubMed ID: 16307502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
    Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
    Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired methicillin-resistant Staphylococcus aureus: time to address the problem.
    Malebranche DJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):459-61. PubMed ID: 16107190
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW; Bayer AS
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract]   [Full Text] [Related]  

  • 12. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 13. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus.
    Crum NF; Lee RU; Thornton SA; Stine OC; Wallace MR; Barrozo C; Keefer-Norris A; Judd S; Russell KL
    Am J Med; 2006 Nov; 119(11):943-51. PubMed ID: 17071162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of methicillin-resistant Staphylococcus aureus.
    Cortazal M; Soule BM; Jarvis WR
    Am J Infect Control; 2006 Dec; 34(10):613-5. PubMed ID: 17161734
    [No Abstract]   [Full Text] [Related]  

  • 15. Community-acquired methicillin-resistant Staphylococcus aureus infections.
    Maltezou HC; Giamarellou H
    Int J Antimicrob Agents; 2006 Feb; 27(2):87-96. PubMed ID: 16423509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, epidemiological, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Palavecino E
    Methods Mol Biol; 2007; 391():1-19. PubMed ID: 18025665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital.
    Navarro MB; Huttner B; Harbarth S
    Curr Opin Infect Dis; 2008 Aug; 21(4):372-9. PubMed ID: 18594289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
    Cunha BA
    J Hosp Infect; 2008 Mar; 68(3):271-3. PubMed ID: 18289722
    [No Abstract]   [Full Text] [Related]  

  • 20. Community acquired methicillin-resistant Staphylococcus aureus update.
    Dugan MA
    Pa Nurse; 2006 Mar; 61(1):29, 31. PubMed ID: 16625775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.